About

Viviane Monges has served as a member of ADC Therapeutics' board of directors since June 2021 and has more than 30 years of executive-level financial leadership experience with global corporations, predominantly in the pharmaceutical industry. From 2015 to 2017 she served as Chief Financial Officer of the Business Excellence Division at Nestle, and previously as Group CFO at Galderma; EMEA CFO and then Global CFO of the OTC Division at Novartis; and CFO of the Europe Region and of the Global Pharma Business unit at Wyeth Pharmaceuticals/Pfizer. She also serves on the boards of bioMerieux and Pharvaris, and previously served on the boards of UCB, EUROAPI, Idorsia and DBV Technologies. She holds a B.A. and an M.B.A. in finance and public administration from the Ecole Superieure de Commerce de Paris.

Roles

ADC Therapeutics SA
Director · Current role
June 2021–present
Nestle, S.A.
CFO, Business Excellence Division
2015 - 2017
Galderma S.A.
Group CFO
—
Novartis (OTC Division)
EMEA CFO then Global CFO
—
Wyeth Pharmaceuticals / Pfizer
CFO, Europe Region and Global Pharma Business unit
—

External Roles

bioMerieux SA
Director
—
Pharvaris
Director
—
Novo Holdings
Board member
—
Ferring Pharmaceuticals
Board member
—

Director Compensation

FY 2025
Fees earned or paid in cash
$71,346
ComponentAnnual cash retainer plus committee and leadership retainers earned in fiscal 2025
Stock awards
$143,600
ComponentAnnual RSU grant, ASC 718 grant-date fair value
All other compensation
$31,468
ComponentSocial security contributions and certain non-mandatory local benefits
Total
$246,414

Also at ADC Therapeutics SA

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.